BCM
TIL icon

BML Capital Management’s Instil Bio TIL Stock Holding History

BML Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.96M Hold
645,600
– – 2.82% 9
2026
Q1 		$5.32M Hold
645,600
– – 3.42% 9
2025
Q4 		$7.1M Hold
645,600
– – 6.14% 4
2025
Q3 		$11.5M Buy
645,600
+110,701
+21% +$2.81M 10.56% 4
2025
Q2 		$11.1M Buy
534,899
+118,179
+28% +$2.47M 8.43% 4
2025
Q1 		$7.23M Buy
416,720
+16,720
+4% +$347K 5.85% 6
2024
Q4 		$7.64M Buy
400,000
+65,000
+19% +$1.98M 4.74% 6
2024
Q3 		$22.6M Sell
335,000
-56,103
-14% -$1.32M 13.27% 2
2024
Q2 		$4.02M Buy
391,103
+42,368
+12% +$458K 2.87% 8
2024
Q1 		$3.77M Buy
+348,735
New +$3.82M 2.48% 9

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

BML Capital Management's TIL Position: Q2 2026 in Review

BML Capital Management held its Instil Bio (TIL) position steady in Q2 2026 at 645,600 shares worth $4.96M. The position accounts for 2.82% of the portfolio, ranked #9.

BML Capital Management first reported a position in TIL in Q1 2024 and has held it in 10 quarters since. The position peaked at $22.6M in Q3 2024. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • BML Capital Management held 645,600 shares of Instil Bio worth $4.96M as of Q2 2026.
  • BML Capital Management left its Instil Bio share count unchanged in Q2 2026.
  • Instil Bio made up 2.82% of BML Capital Management's portfolio in Q2 2026, its #9 holding.
  • BML Capital Management first reported a position in Instil Bio in Q1 2024 and has held it in 10 quarters since.
  • BML Capital Management's Instil Bio position peaked at $22.6M in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on BML Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.